McIlrath & Eck’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.62K | Sell |
40
-42
| -51% | -$3.85K | ﹤0.01% | 1296 |
|
|
2025
Q4 | $7.37K | Hold |
82
| – | – | ﹤0.01% | 713 |
|
|
2025
Q3 | $8.07K | Hold |
82
| – | – | ﹤0.01% | 671 |
|
|
2025
Q2 | $7.47K | Hold |
82
| – | – | ﹤0.01% | 649 |
|
|
2025
Q1 | $9.27K | Hold |
82
| – | – | ﹤0.01% | 617 |
|
|
2024
Q4 | $8.65K | Hold |
82
| – | – | ﹤0.01% | 644 |
|
|
2024
Q3 | $8.84K | Hold |
82
| – | – | ﹤0.01% | 645 |
|
|
2024
Q2 | $8.89K | Buy |
82
+41
| +100% | +$4.83K | ﹤0.01% | 627 |
|
|
2024
Q1 | $5.4K | Sell |
41
-41
| -50% | -$5.12K | ﹤0.01% | 705 |
|
|
2023
Q4 | $9.96K | Hold |
82
| – | – | ﹤0.01% | 557 |
|
|
2023
Q3 | $9.17K | Hold |
82
| – | – | ﹤0.01% | 560 |
|
|
2023
Q2 | $11.9K | Hold |
82
| – | – | ﹤0.01% | 539 |
|
|
2023
Q1 | $10.5K | Hold |
82
| – | – | ﹤0.01% | 543 |
|
|
2022
Q4 | $10.4K | Buy |
82
+1
| +1% | +$116 | ﹤0.01% | 526 |
|
|
2022
Q3 | $9K | Hold |
81
| – | – | ﹤0.01% | 566 |
|
|
2022
Q2 | $9K | Hold |
81
| – | – | ﹤0.01% | 536 |
|
|
2022
Q1 | $10K | Sell |
81
-2
| -2% | -$241 | ﹤0.01% | 536 |
|
|
2021
Q4 | $10K | Hold |
83
| – | – | ﹤0.01% | 541 |
|
|
2021
Q3 | $12K | Hold |
83
| – | – | ﹤0.01% | 503 |
|
|
2021
Q2 | $13K | Hold |
83
| – | – | ﹤0.01% | 486 |
|
|
2021
Q1 | $13K | Hold |
83
| – | – | ﹤0.01% | 442 |
|
|
2020
Q4 | $12K | Hold |
83
| – | – | ﹤0.01% | 394 |
|
|
2020
Q3 | $11K | Hold |
83
| – | – | ﹤0.01% | 368 |
|
|
2020
Q2 | $10K | Hold |
83
| – | – | ﹤0.01% | 362 |
|
|
2020
Q1 | $8K | Hold |
83
| – | – | ﹤0.01% | 356 |
|
|
2019
Q4 | $12K | Hold |
83
| – | – | 0.01% | 341 |
|
|
2019
Q3 | $11K | Buy |
83
+1
| +1% | +$129 | 0.01% | 332 |
|
|
2019
Q2 | $10K | Hold |
82
| – | – | 0.01% | 345 |
|
|
2019
Q1 | $10K | Hold |
82
| – | – | 0.01% | 345 |
|
|
2018
Q4 | $8K | Sell |
82
-42
| -34% | -$4.72K | 0.01% | 312 |
|
|
2018
Q3 | $16K | Buy |
124
+83
| +202% | +$9.87K | 0.01% | 240 |
|
|
2018
Q2 | $4K | Hold |
41
| – | – | ﹤0.01% | 405 |
|
|
2018
Q1 | $4K | Sell |
41
-47
| -53% | -$5.46K | ﹤0.01% | 384 |
|
|
2017
Q4 | $10K | Buy |
+88
| New | +$9.95K | 0.01% | 285 |
|
Other funds holding ZBH
McIlrath & Eck's ZBH Position: Q1 2026 in Review
McIlrath & Eck reduced its Zimmer Biomet (ZBH) stake by 51% in Q1 2026, selling an estimated $3.85K and leaving 40 shares worth $3.62K. The position accounts for ﹤0.01% of the portfolio, ranked #1296.
McIlrath & Eck first reported a position in ZBH in Q4 2017 and has held it in 34 quarters since. The position peaked at $16K in Q3 2018. 916 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- McIlrath & Eck held 40 shares of Zimmer Biomet worth $3.62K as of Q1 2026.
- McIlrath & Eck sold 42 Zimmer Biomet shares in Q1 2026, an estimated $3.85K.
- Zimmer Biomet made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #1296 holding.
- McIlrath & Eck first reported a position in Zimmer Biomet in Q4 2017 and has held it in 34 quarters since.
- McIlrath & Eck's Zimmer Biomet position peaked at $16K in Q3 2018.
- 916 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.